Provided by Tiger Fintech (Singapore) Pte. Ltd.

Inovio Pharmaceuticals

2.22
+0.01000.45%
Volume:503.64K
Turnover:1.13M
Market Cap:81.42M
PE:-0.71
High:2.30
Open:2.19
Low:2.19
Close:2.21
Loading ...

Inovio Pharmaceuticals Inc. Stock Advances 7.3%, Outperforms Competitors

Dow Jones
·
Yesterday

Inovio Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
24 Jun

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
19 Jun

Inovio Pharmaceuticals Inc. Stock Falls 5.0%, Underperforms Competitors

Dow Jones
·
18 Jun

Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
13 Jun

Inovio Pharmaceuticals Inc. Stock Sheds 5.8%, Underperforms Competitors

Dow Jones
·
12 Jun

Inovio Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
10 Jun

Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
06 Jun

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
05 Jun

Inovio Pharmaceuticals Inc. Stock Rises 5.0%, Outperforms Competitors

Dow Jones
·
03 Jun

Inovio Pharmaceuticals Inc. Stock Sheds 6.1%, Underperforms Competitors

Dow Jones
·
31 May

Inovio Pharmaceuticals Inc. Stock Advances 6.5%, Outperforms Competitors

Dow Jones
·
30 May

Inovio Pharmaceuticals Inc. Stock Rises Tuesday, Still Underperforms Market

Dow Jones
·
28 May

Inovio Pharmaceuticals Holds Annual Stockholders Meeting

TIPRANKS
·
23 May

Inovio Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
22 May

Inovio Pharmaceuticals Inc. Stock Rallies 2.9%, Outperforms Competitors

Dow Jones
·
21 May

Inovio Pharmaceuticals Inc. Stock Rises 5.1%, Outperforms Competitors

Dow Jones
·
17 May

Inovio Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
15 May

Inovio Pharma Price Target Maintained With a $5.00/Share by RBC Capital

Dow Jones
·
14 May

Inovio Pharma Is Maintained at Outperform by Oppenheimer

Dow Jones
·
14 May